Abstract:Liang Tan, 1, &ast Feilong Wang, 1, &ast Yi Huang, 2 Chuhua Fu, 3 Haijun Zhang, 4 Jianfei Feng, 5 Yincai Xu, 6 Xinzhen Ye, 7 Rongrui Tang, 8 Yinglian Chen, 9 Liansheng Mou, 10 Ronghao Li, 11 Jingyu Chen, 1 Jishu Xian 1 1 Department of Neurosurgery, Southwest Hospital, Army Medical University, Chongqing, People's Republic of China; 2 Department of Neurosurgery, The Ninth People's Hospital of Chongqing, Chongqing, People's Republic of China; 3 Department of Neurosurgery, Xiangyang No.1 People's Hospital, University of Medicine, Xiangyang, Hubei, People's Republic of China; 4 Department of Neurosurgery, Kaifeng Central Hospital, Kaifeng, Henan, People's Republic of China; 5 Department of Encephalopathy, Beibei Traditional Chinese Medical Hospital, Chongqing, People's Republic of China; 6 Department of Neurosurgery, Zheng Coal General Hospital, Zhengzhou, Henan Province, People's Republic of China; 7 Department of Neurosurgery, Songshan General Hospital, Chongqing, People's Republic of China; 8 Department of Neurosurgery, University-Town Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 9 Zhuhai Brainlightning Research Institute, Zhuhai City, Guangdong, People's Republic of China; 10 Department of Neurosurgery, Liangping District People's Hospital, Chongqing, People's Republic of China; 11 Department of Basic Medicine, Army Medical University, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jingyu Chen; Jishu Xian, Email ; Purpose: The SARS-CoV-2 infection cases are increasing rapidly in neuro-intensive care units (neuro-ICUs) at the beginning of 2023 in China. We aimed to characterize the prevalence, risk factors, and prognosis of critically ill patients treated in neuro-ICUs. Materials and Methods: In the prospective, multicenter, observational registry study, critically ill patients with intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and traumatic brain injury (TBI) admitted to eight Chinese neuro-ICUs between Feb 16, 2023, to Apr 30, 2023 were enrolled for the study. Mortality and ICU stay day were used as the primary outcomes. Results: 131 patients were finally included and analyzed (mean age 60.36 years [SD 13.81], 64.12% male, 39.69% SARS-CoV-2 infected). The mortality is higher in the SARS-CoV-2 infection group without statistical signification (7.69% vs 5.06%, p> 0.05). The length of stay (LOS) in neuro-ICUs was significantly longer among the SARS-CoV-2 infection patients (7(1– 12) vs 4(1– 8), p< 0.01), with increased viral pneumonia occurrence (58.54% vs 7.32%, p< 0.01). SARS-CoV-2 infection, surgery, and low GCS scores were independent risk factors for prolonged LOS, and respiratory/renal failure were independent risk factors for death. Conclusion: Based on the present neuro-ICU cohort, SARS-CoV-2 infection was a significant risk for the prolonged LOS of neuro-critically ill patients. Trial Registration: Registered with Chictr.org.cn (ChiCTR2300068355) at 16 February 2023, Prospective registration. https://www.chictr.org.cn/showproj.html?proj=188252 . Keywords: SARS-CoV-2, intensive care unit, intracerebral hemorrhage, subarachnoid hemorrhage, traumatic brain injury The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic, resulting in a substantial number of patients needing critical care. SARS-CoV-2 primarily affects the respiratory system, resulting in cough, fever, and dyspnea. 1 Recent studies have indicated that SARS-CoV-2 has the potential to impact various organ systems, including the central nervous system (CNS). 2 Patients with pre-existing critical neurological conditions, such as intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and traumatic brain injury (TBI), who subsequently acquire SARS-CoV-2 infection, may experience unfavorable outcomes when admitted to neuro-intensive care units (neuro-ICUs). SARS-CoV-2 has the ability to invade endothelial cells and induce widespread endothelial inflammation in individuals diagnosed with COVID-19. 3 Viral replication occurs in multiple respiratory and non-respiratory tissues during early infection, leading to systemic infection and persistence in the body for months. 4 Patients admitted to neuro-ICUs are susceptible to SARS-CoV-2 infection and at risk of severe complications. Ischemic stroke can also manifest as a symptom of COVID-19 -Abstract Truncated-

Outcomes for people admitted to Australian and New Zealand intensive care units with primary, exacerbating, or incidental SARS‐CoV‐2 infections, 2022–23: a retrospective analysis of ANZICS data

Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023

Comparative analysis of mortality in patients admitted with an infection with influenza A/B virus, respiratory syncytial virus, rhinovirus, metapneumovirus or SARS‐CoV‐2

Trends in risks of severe events and lengths of stay for COVID-19 hospitalisations in England over the pre-vaccination era: results from the Public Health England SARI-Watch surveillance scheme

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE Study

Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study

Co-infection in critically ill patients with COVID-19: an observational cohort study from England

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Secondary infections in critically ill patients with viral pneumonia due to COVID-19 and influenza: a historical cohort study

Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study

Comparison of Clinical Characteristics and Outcomes in Intensive Care Units Between Patients with Coronavirus Disease 2019 (COVID-19) and Patients with Influenza: A Systematic Review and Meta-Analysis

In-Hospital mortality for immunocompromised patients with SARS-CoV-2 community-acquired pneumonia (CAP)

ICU Mortality Across Prepandemic and Pandemic Cohorts in a Resource-Limited Setting: A Critical Care Resiliency Analysis From South Africa

The Impact of SARS-CoV-2 Infection on the Length of Stay in the Neuro-ICU:A Prospective Multicenter Cohort Study in Eight Neuro-ICU, China Between February and April 2023

Adults with Severe Acute Respiratory Illness in Glasgow, 2021-22: A Prospective Cohort Study

Management and outcomes of COVID-19 patients admitted in a newly created ICU and an expert ICU, a retrospective observational study

Clinical characteristics and outcomes of COVID-19 cases admitted to adult intensive care units during the pandemic: A single center experience

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience

Analysis of Predictors and Outcomes of COVID-19 Patients Requiring ICU Admission from COVID-19 Registry, India